Unique ID issued by UMIN | UMIN000051017 |
---|---|
Receipt number | R000058160 |
Scientific Title | A role of transcutaneous vagus nerve stimulation on left ventricular function and afterload in Takotsubo syndrome |
Date of disclosure of the study information | 2023/06/01 |
Last modified on | 2024/05/09 09:19:48 |
A role of transcutaneous vagus nerve stimulation on left ventricular function and afterload in Takotsubo syndrome
A role of transcutaneous vagus nerve stimulation on left ventricular function and afterload in Takotsubo syndrome
A role of transcutaneous vagus nerve stimulation on left ventricular function and afterload in Takotsubo syndrome
Vagus nerve stimulation and left ventricle in Takotsubo syndrome
Japan |
Takotsubo syndrome
Cardiology |
Others
NO
Low-level tragus stimulation (LLTS) of transcutaneous vagus nerve stimulation (tVNS) is expected to stabilize the sympatho-vagal balance, and is hypothesized to improve left ventricular function and reduce afterload in patients with Takotsubo syndrome. We investigate the acute effects of LLTS compared with sham stimulation.
Efficacy
Changes in left ventricular global strain and afterload before and after tVNS
Interventional
Cross-over
Randomized
Individual
Single blind -investigator(s) and assessor(s) are blinded
Placebo
2
Treatment
Device,equipment |
In the active LLTS precedent group, a device clip is attached to the left tragus, and stimulation was performed for 1 hour as vagus nerve auricular stimulation. In the Sham stimulation precedent group, a clip was attached to the left earlobe, and stimulation was performed for 1 hour.
After the Intervention 1, with resting for 1 hour, Sham stimulation is performed in the Active LLTS precedent group, and Active LLTS is performed in the Sham stimulation precedence group, and crossover is performed.
65 | years-old | <= |
Not applicable |
Female
1. The patients diagnosed as Takotsubo syndrome in Hiroshima City Asa Hospital
2. The Takotsubo syndrome patients who have systolic blood pressure more than 100mmHg.
3. The Takotsubo syndrome patients who provide written informed consent.
1. The Takotsubo syndrome patients who have multiple organ failure.
2. The Takotsubo syndrome patients who have systolic blood pressure less than 100mmHg.
3. The Takotsubo syndrome patients who have severe bradycardia.
4. The Takotsubo syndrome patients who have sepsis.
5. The Takotsubo syndrome patients who did not provide written informed consent.
6
1st name | Michiaki |
Middle name | |
Last name | Nagai |
Hiroshima City Asa Hospital
Department of Cardiology
731-0293
1-2-1, Kameyamaminami, Aaskita-ku, Hiroshima
082-815-5211
nagai10m@r6.dion.ne.jp
1st name | Michiaki |
Middle name | |
Last name | Nagai |
Hiroshima City Asa Hospital
Department of Cardiology
731-0293
1-2-1, Kameyamaminami, Aaskita-ku, Hiroshima
082-815-5211
nagai10m@r6.dion.ne.jp
Hiroshima City Asa Hospital
Self funding
Self funding
Hiroshima City Asa Hospital
1-2-1, Kameyamaminami, Aaskita-ku, Hiroshima
082-815-5211
nagai10m@r6.dion.ne.jp
NO
2023 | Year | 06 | Month | 01 | Day |
Unpublished
Completed
2023 | Year | 04 | Month | 01 | Day |
2023 | Year | 05 | Month | 29 | Day |
2023 | Year | 05 | Month | 31 | Day |
2023 | Year | 07 | Month | 01 | Day |
2023 | Year | 05 | Month | 09 | Day |
2024 | Year | 05 | Month | 09 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058160